Keros Therapeutics Inc (KROS)

Operating Expenses

$115.68M

TTM · Period ending: · USD

KROS logo

KROS Operating Expenses

Latest reported$115.68M
KROS Operating Expenses ($11.32M → $115.68M)
High-resolution chart · PNG

KROS operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
171,929,000
214,383,000
170,092,000
114,790,000
76,473,000
46,052,000
20,005,000
11,321,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.